ESC & iPSC News Volume 16.19 | May 19 2021

    0
    111






    ESC 16.19 | May 19 2021


    ESC & iPSC News by STEMCELL Technologies
    Vol. 16.19 – 19 May, 2021
    TOP STORY

    CTCF Mediates Dosage- and Sequence-Context-Dependent Transcriptional Insulation by Forming Local Chromatin Domains

    Investigators explored the sequence requirements of CCCTC-binding factor (CTCF)-mediated transcriptional insulation using a sensitive insulator reporter in mouse ESCs.
    [Nature Genetics]

    Abstract

    Survey results on the needs and challenges in the human pluripotent stem cell field
    PUBLICATIONSRanked by the impact factor of the journal

    Gene Therapy Restores Dopamine Transporter Expression and Ameliorates Pathology in iPSC and Mouse Models of Infantile Parkinsonism

    Using patient-derived iPSCs, researchers generated a midbrain dopaminergic neuron model of dopamine transporter deficiency syndrome that exhibited marked impairment of dopamine transporter activity, apoptotic neurodegeneration associated with TNFα-mediated inflammation, and dopamine toxicity.
    [Science Translational Medicine]

    Abstract

    Comparative Evaluation of Isogenic Mesodermal and Ectomesodermal Chondrocytes from Human iPSCs for Cartilage Regeneration

    Investigators differentiated human iPSCs into the mesodermal and ectomesodermal lineages to prepare isogenic mesodermal cell–derived chondrocytes and neural crest cell–derived chondrocytes for comparative evaluation.
    [Science Advances]

    Full Article

    Generation of Hypoimmunogenic T Cells from Genetically Engineered Allogeneic Human Induced Pluripotent Stem Cells

    Researchers reported the generation of hypoimmunogenic cancer-antigen-specific T cells derived from induced pluripotent stem cells lacking β2-microglobulin, the class-II major histocompatibility complex (MHC) transactivator and the natural killer cell-ligand poliovirus receptor CD155, and expressing single-chain MHC class-I antigen E.
    [Nature Biomedical Engineering]

    Abstract

    16p11.2 Deletion Is Associated with Hyperactivation of Human iPSC-Derived Dopaminergic Neuron Networks and Is Rescued by RHOA Inhibition In Vitro

    Researchers showed that 16p11.2 deletion iPSC-derived dopaminergic neurons have increased soma size and synaptic marker expression compared to isogenic control lines.
    [Nature Communications]

    Full Article

    Pluripotent Stem Cell-Derived Endometrial Stromal Fibroblasts in a Cyclic, Hormone-Responsive, Coculture Model of Human Decidua

    Scientists reported a protocol differentiating human PSCs into endometrial stromal fibroblasts that were highly pure and able to decidualize.
    [Cell Reports]

    Full ArticleGraphical Abstract

    GATA6 Defines Endoderm Fate by Controlling Chromatin Accessibility during Differentiation of Human-Induced Pluripotent Stem Cells

    Using PSCs as a model of human development, researchers revealed that GATA6 was integral to the establishment of the endoderm enhancer network via the induction of chromatin accessibility and histone modifications.
    [Cell Reports]

    Full ArticleGraphical Abstract

    Novel Fragile X Syndrome 2D and 3D Brain Models Based on Human Isogenic FMRP-KO iPSCs

    Scientists generated 2D and 3D in vitro human Fragile X syndrome model systems based on isogenic fragile X mental retardation protein (FMRP) knock-out mutant and wild-type human iPSC lines.
    [Cell Death & Disease]

    Full Article

    PHAROH lncRNA Regulates Myc Translation in Hepatocellular Carcinoma via Sequestering TIAR

    Scientists identified a long non-coding RNA, Gm19705, that was over-expressed in hepatocellular carcinoma and mouse ESCs.
    [eLife]

    Abstract

    New mTeSRâ„¢ Plus hPSC Maintenance Medium
    REVIEWS

    Urine-Derived Induced Pluripotent/Neural Stem Cells for Modeling Neurological Diseases

    Researchers describe the cellular and molecular properties of urine-derived stem cells, their differentiation potency, different reprogramming methods for the generation of iPSCs/induced neural stem cells, and their potential applications in modeling neurological diseases.
    [Cell & Bioscience]

    Full Article

    INDUSTRY AND POLICY NEWS

    Accelerated Biosciences’ Immune-Privileged Human Trophoblast Stem Cells (hTSCs) Offer Breakthrough Opportunities in Cancer-Targeting Therapeutics and Regenerative Medicine Treatments

    Accelerated Biosciences announced new data that further demonstrates statistically significant cytolysis with iPSC-derived natural killer cells programmed from its ethically sourced hTSCs.
    [Accelerated Biosciences (BusinessWire, Inc.)]

    Press Release

    FEATURED EVENT

    Congress of the European Hematology Association

    June 9 – 17, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Stem Cell Scientist – Developmental Biology and hiPSC

    National Institutes of Health – Rockville, Maryland, United States

    Research Associate – Cancer Stem Cell Biology

    City of Hope – Duarte, California, United States

    Postdoctoral Researcher – Cell Fate Engineering

    German Cancer Research Center – Heidelberg, Germany

    Bioinformatician – Preclinical Innovation

    National Institutes of Health – Rockville, Maryland, United States

    Postdoctoral Fellow – Stem Cell Differentiation

    NYU Langone Medical Center – New York, New York, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    ESC & iPSC News Twitter